• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌诊断和治疗时间延迟的预后影响:津巴布韦帕里伦亚瓦医院患者的探索性数据分析

Prognostic impact of diagnostic and therapeutic time delays in breast cancer: an exploratory data analysis for patients at Parirenyatwa Hospital, Zimbabwe.

作者信息

Saruchera Bester, Bodhlyera Oliver, Mwambi Henry, Ndlovu Ntokozo

机构信息

School of Mathematics, Statistics and Computer Science, University of KwaZulu-Natal, Private Bag X01, Scottsville 3209, South Africa.

Department of Oncology, Faculty of Medicine and Health Sciences, University of Zimbabwe, P.O.Box MP167. Mt Pleasant, Harare.

出版信息

Afr Health Sci. 2024 Sep;24(3):156-172. doi: 10.4314/ahs.v24i3.20.

DOI:10.4314/ahs.v24i3.20
PMID:40777954
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12327112/
Abstract

OBJECTIVE

This paper seeks to investigate factors related to time delays for diagnosis and treatment in breast cancer patients at Parirenyatwa Hospital in Zimbabwe and subsequently evaluate the effects of presentation and diagnosis delays on cancer stage.

METHODS

The study was done for 379 patients with histologically diagnosed invasive breast cancer, from 2015 through to 2019. The study sought to identify factors associated with the time delays ( months)using parametric and non-parametric methods, depending on whether underlying assumptions of such tests are met. A multiple logistic regression model was also used to analyse the association between factors, primary delay, secondary delay variables and cancer stage.

RESULTS

The median of the primary, secondary and treatment delay were found to be 7.6, 1 and 0.4 months respectively. Rural residence, Karnofsky Performance Score below 70%, hypertension comorbidity, tumor size (>5cm) and well differentiated tumors (grade 1) were significant factors for delayed presentation. Longer primary delay times and post-menopausal status were associated with secondary delay. Advanced cancer stage at diagnosis and those on medical aid were more likely to have a delay in treatment onset.

CONCLUSION

Primary and secondary delay were predictive of advanced disease using logistic regression.

摘要

目的

本文旨在调查津巴布韦帕里仁亚瓦医院乳腺癌患者诊断和治疗时间延迟的相关因素,并随后评估就诊延迟和诊断延迟对癌症分期的影响。

方法

该研究针对2015年至2019年期间379例经组织学诊断为浸润性乳腺癌的患者进行。根据此类检验的基本假设是否满足,该研究试图使用参数和非参数方法确定与时间延迟(月)相关的因素。还使用多元逻辑回归模型分析因素、初次延迟、二次延迟变量与癌症分期之间的关联。

结果

发现初次延迟、二次延迟和治疗延迟的中位数分别为7.6个月、1个月和0.4个月。农村居民、卡诺夫斯基体能状态评分低于70%、高血压合并症、肿瘤大小(>5cm)和高分化肿瘤(1级)是就诊延迟的重要因素。较长的初次延迟时间和绝经后状态与二次延迟相关。诊断时癌症分期较晚以及接受医疗救助的患者更有可能出现治疗开始延迟。

结论

使用逻辑回归分析,初次延迟和二次延迟可预测疾病进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758e/12327112/58ca192f04b4/AFHS2403-0156Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758e/12327112/0b2b5814368b/AFHS2403-0156Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758e/12327112/9c061c396119/AFHS2403-0156Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758e/12327112/58ca192f04b4/AFHS2403-0156Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758e/12327112/0b2b5814368b/AFHS2403-0156Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758e/12327112/9c061c396119/AFHS2403-0156Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/758e/12327112/58ca192f04b4/AFHS2403-0156Fig1.jpg

相似文献

1
Prognostic impact of diagnostic and therapeutic time delays in breast cancer: an exploratory data analysis for patients at Parirenyatwa Hospital, Zimbabwe.乳腺癌诊断和治疗时间延迟的预后影响:津巴布韦帕里伦亚瓦医院患者的探索性数据分析
Afr Health Sci. 2024 Sep;24(3):156-172. doi: 10.4314/ahs.v24i3.20.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
4
A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness.乳腺癌护理及时性的医疗保健可及性因素及差异的潜在类别评估
PLoS Med. 2024 Dec 2;21(12):e1004500. doi: 10.1371/journal.pmed.1004500. eCollection 2024 Dec.
5
A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.一项关于恶性脊柱转移瘤的证据的系统回顾:自然病史和识别高风险椎体骨折和脊髓压迫患者的技术。
Health Technol Assess. 2013 Sep;17(42):1-274. doi: 10.3310/hta17420.
6
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.乳腺密度、内分泌治疗与乳腺癌风险:预后和预测生物标志物综述。
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.
9
Association of Neighborhood Deprivation with Stage at Diagnosis and Treatment Delay for Breast Cancer in Philadelphia.费城社区贫困状况与乳腺癌诊断分期及治疗延迟的关联
Ann Surg Oncol. 2025 May 12. doi: 10.1245/s10434-025-17367-w.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
Associations between health insurance status, neighborhood deprivation, and treatment delays in women with breast cancer living in Georgia.佐治亚州女性乳腺癌患者的医疗保险状况、居住社区贫困程度与治疗延误的相关性。
Cancer Med. 2023 Aug;12(16):17331-17339. doi: 10.1002/cam4.6341. Epub 2023 Jul 12.
2
[Not Available].[无可用内容]。
Salud Publica Mex. 2021 Dec 8;64(1):87-95. doi: 10.21149/12472.
3
Factors Influencing Total Delay of Breast Cancer in Northeast of China.影响中国东北地区乳腺癌总延误时间的因素
Front Oncol. 2022 Mar 2;12:841438. doi: 10.3389/fonc.2022.841438. eCollection 2022.
4
Impact of prior cancer on the overall survival of patients with nasopharyngeal carcinoma.既往癌症对鼻咽癌患者总生存的影响。
Am J Otolaryngol. 2022 Jan-Feb;43(1):103235. doi: 10.1016/j.amjoto.2021.103235. Epub 2021 Sep 15.
5
Evaluating the impact of multivariate imputation by MICE in feature selection.评估 MICE 进行多元插补对特征选择的影响。
PLoS One. 2021 Jul 28;16(7):e0254720. doi: 10.1371/journal.pone.0254720. eCollection 2021.
6
Factors Associated with Delay in Breast Cancer Presentation at the Only Oncology Center in North East Ethiopia: A Cross-Sectional Study.埃塞俄比亚东北部唯一肿瘤中心乳腺癌就诊延迟的相关因素:一项横断面研究
J Multidiscip Healthc. 2021 Mar 19;14:681-694. doi: 10.2147/JMDH.S301337. eCollection 2021.
7
Risk factors associated with loss to follow-up of breast cancer patients: A retrospective analysis.与乳腺癌患者失访相关的风险因素:一项回顾性分析。
Breast. 2021 Jun;57:36-42. doi: 10.1016/j.breast.2021.02.012. Epub 2021 Mar 2.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
Few Losses to Follow-up in a Sub-Saharan African Cancer Cohort via Active Mobile Health Follow-up.通过主动移动健康随访,在撒哈拉以南非洲癌症队列中几乎没有随访损失。
Am J Epidemiol. 2020 Oct 1;189(10):1185-1196. doi: 10.1093/aje/kwaa070.
10
The evolving epidemic of breast cancer in sub-Saharan Africa: Results from the African Cancer Registry Network.撒哈拉以南非洲地区乳腺癌流行趋势的演变:来自非洲癌症登记网络的结果。
Int J Cancer. 2020 Oct 15;147(8):2131-2141. doi: 10.1002/ijc.33014. Epub 2020 Apr 30.